Used as a key intermediate in the synthesis of tyrosine kinase inhibitors, particularly in anticancer drug development. It plays a role in targeting signaling pathways involved in tumor growth and proliferation. Its structure supports binding to enzyme active sites, making it valuable in pharmaceutical research for designing inhibitors with high selectivity and potency. Commonly utilized in the development of targeted therapies for cancers such as chronic myeloid leukemia and non-small cell lung cancer. Also employed in structure-activity relationship (SAR) studies to optimize drug candidates for improved efficacy and reduced side effects.